HIV CURE SCIENTIFIC WORKING GROUP (SWG 1) PROJECT SUMMARY The HIV Cure Scientific Working Group (SWG) will serve as the focal point for investigators conducting HIV cure research in Washington, DC. Led by a core group of NIH-funded laboratory scientists, clinicians and epidemiologists, and in partnership with community members actively engaged in the HIV cure research field, the SWG will engage a wider circle of early stage and new investigators as well as intramural NIH scientists to stimulate the development of new grant proposals and publications in this high priority area. Previously, the HIV Cure SWG provided substantial support for the successful application to establish the BELIEVE Martin Delaney Collaboratory. Following the relocation of BELIEVE to Cornell University, the HIV Cure SWG was reconstituted in January 2019 to further galvanize and coordinate HIV cure research in DC. The HIV Cure SWG will achieve its objectives through regular monthly meetings, HIV cure-related seminars, strategic outreach to investigators in the DC area, promotion of new HIV cure-related DC CFAR pilot awards and NIH grant applications and encouragement and review of HIV cure-related manuscripts.
The Specific Aims of the HIV Cure SWG are: 1) to promote scientific discovery in HIV cure research in Washington, DC, 2) to stimulate and support the development of innovative, trans-disciplinary and multi- institutional HIV cure-related grant applications and manuscripts, and 3) to support early stage, established and new and transitioning investigators in HIV cure research, with an emphasis on women and underrepresented minorities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI117970-06
Application #
9986264
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
George Washington University
Department
Type
DUNS #
043990498
City
Washington
State
DC
Country
United States
Zip Code
20052
Leal, Fabio E; Menezes, Soraya Maria; Costa, Emanuela A S et al. (2018) Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-? Response in HTLV-1-Associated Neuroinflammation. Front Microbiol 9:985
Furler, Robert L; Nixon, Douglas F; Brantner, Christine A et al. (2018) TGF-? Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction. Cancers (Basel) 10:
Keene, Danya E; Rosenberg, Alana; Schlesinger, Penelope et al. (2018) Navigating Limited and Uncertain Access to Subsidized Housing After Prison. Hous Policy Debate 28:199-214
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Yamanis, Thespina J; Zea, Maria Cecilia; Ramé Montiel, Ana Karen et al. (2018) Immigration Legal Services as a Structural HIV Intervention for Latinx Sexual and Gender Minorities. J Immigr Minor Health :
Calabrese, Sarah K; Earnshaw, Valerie A; Underhill, Kristen et al. (2018) Prevention paradox: Medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. J Int AIDS Soc 21:e25147
Algarin, Angel B; Ibañez, Gladys E (2018) PrEP-ared Against HIV, but Not Sexually Transmitted Infections. Am J Public Health 108:e1
Page, Kathleen R; Grieb, Suzanne Dolwick; Nieves-Lugo, Karen et al. (2018) Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings. Lancet HIV 5:e597-e604
Xia, Jie; Reid, Terry-Elinor; Wu, Song et al. (2018) Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis. J Chem Inf Model 58:1104-1120
Macedo, Amanda B; Resop, Rachel S; Martins, Laura J et al. (2018) Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus. AIDS Res Hum Retroviruses 34:769-777

Showing the most recent 10 out of 98 publications